Search Results

Filter
  • 1-10 of  367 results for ""LEIOMYOSARCOMA""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Immune evasion in lung metastasis of leiomyosarcoma: upregulation of EPCAM inhibits CD8 + T cell infiltration.

  • Authors : Kanahori M; Department of Orthopaedic Surgery, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan.; Shimada E

Subjects: Leiomyosarcoma*/Leiomyosarcoma*/Leiomyosarcoma*/genetics ; Leiomyosarcoma*/Leiomyosarcoma*/Leiomyosarcoma*/pathology ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/genetics

  • Source: British journal of cancer [Br J Cancer] 2024 Apr; Vol. 130 (7), pp. 1083-1095. Date of Electronic Publication: 2024 Jan 30.Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata.

  • Authors : Woll PJ; University of Sheffield, Sheffield UK and Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, S10 2JF, UK.; Gaunt P

Subjects: Leiomyosarcoma*/Leiomyosarcoma*/Leiomyosarcoma*/drug therapy ; Sarcoma, Synovial*/Sarcoma, Synovial*/Sarcoma, Synovial*/chemically induced ; Sarcoma, Synovial*/Sarcoma, Synovial*/Sarcoma, Synovial*/drug therapy

  • Source: British journal of cancer [Br J Cancer] 2023 Oct; Vol. 129 (9), pp. 1490-1499. Date of Electronic Publication: 2023 Sep 08.Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Eribulin versus dacarbazine in patients with leiomyosarcoma: subgroup analysis from a phase 3, open-label, randomised study.

  • Authors : Blay JY; Department of Medical Oncology, Université Claude Bernard & Centre Léon Bérard, Lyon, France. .; Schöffski P

Subjects: Dacarbazine/Dacarbazine/Dacarbazine/*therapeutic use ; Furans/Furans/Furans/*therapeutic use ; Ketones/Ketones/Ketones/*therapeutic use

  • Source: British journal of cancer [Br J Cancer] 2019 May; Vol. 120 (11), pp. 1026-1032. Date of Electronic Publication: 2019 May 08.Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma.

  • Authors : Dantas-Barbosa C; Department of Translational Research & UMR1052, CRCL, Centre Léon Bérard, 28 Rue Laennec, Lyon 69008, France.; Lesluyes T

Subjects: Anilides/Anilides/Anilides/*pharmacology ; Leiomyosarcoma/Leiomyosarcoma/Leiomyosarcoma/*drug therapy ; Proto-Oncogene Proteins/Proto-Oncogene Proteins/Proto-Oncogene Proteins/*genetics

  • Source: British journal of cancer [Br J Cancer] 2017 Dec 05; Vol. 117 (12), pp. 1787-1797. Date of Electronic Publication: 2017 Oct 12.Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcoma.

  • Authors : Vincenzi B; Medical Oncology, Campus Bio-Medico University of Rome, Via Alvaro del Portillo 200, 00128 Rome, Italy.; Stacchiotti S

Subjects: Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/*therapeutic use ; Deoxycytidine/Deoxycytidine/Deoxycytidine/*analogs & derivatives ; Equilibrative Nucleoside Transporter 1/Equilibrative Nucleoside Transporter 1/Equilibrative Nucleoside Transporter 1/*genetics

  • Source: British journal of cancer [Br J Cancer] 2017 Jul 25; Vol. 117 (3), pp. 340-346. Date of Electronic Publication: 2017 Jun 22.Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

T-regulatory cells predict clinical outcome in soft tissue sarcoma patients: a clinico-pathological study.

  • Authors : Smolle MA; Department of Orthopaedics and Trauma, Medical University of Graz, Graz, Austria.; Herbsthofer L

Subjects: B7-H1 Antigen/B7-H1 Antigen/B7-H1 Antigen/*metabolism ; Fibrosarcoma/Fibrosarcoma/Fibrosarcoma/*pathology ; Leiomyosarcoma/Leiomyosarcoma/Leiomyosarcoma/*pathology

  • Source: British journal of cancer [Br J Cancer] 2021 Aug; Vol. 125 (5), pp. 717-724. Date of Electronic Publication: 2021 Jun 14.Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Gene expression profiling identifies distinct molecular subgroups of leiomyosarcoma with clinical relevance.

  • Authors : Lee YF; Institute of Cancer Research, 15 Cotswold Road, Belmont, Sutton, London SM2 5NG, UK.; Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong, China.

Subjects: Gene Expression Profiling* ; Gene Expression Regulation, Neoplastic*; Leiomyosarcoma/Leiomyosarcoma/Leiomyosarcoma/*classification

  • Source: British journal of cancer [Br J Cancer] 2016 Oct 11; Vol. 115 (8), pp. 1000-1007. Date of Electronic Publication: 2016 Sep 08.Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma.

Subjects: Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/*administration & dosage ; Deoxycytidine/Deoxycytidine/Deoxycytidine/*analogs & derivatives ; Docetaxel/Docetaxel/Docetaxel/*administration & dosage

  • Source: British journal of cancer [Br J Cancer] 2018 Aug; Vol. 119 (5), pp. 565-571. Date of Electronic Publication: 2018 Jul 30.Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer.

  • Authors : Kämpjärvi K; Department of Medical Genetics, Genome-Scale Biology Research Program, University of Helsinki, PO Box 63, Helsinki FIN-00014, Finland.; Mäkinen N

Subjects: Colorectal Neoplasms/Colorectal Neoplasms/Colorectal Neoplasms/*genetics ; Leiomyosarcoma/Leiomyosarcoma/Leiomyosarcoma/*genetics ; Mediator Complex/Mediator Complex/Mediator Complex/*genetics

  • Source: British journal of cancer [Br J Cancer] 2012 Nov 06; Vol. 107 (10), pp. 1761-5. Date of Electronic Publication: 2012 Sep 20.Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Prognostic significance of bcl-2 expression in leiomyosarcoma of the uterus.

  • Authors : Zhai YL; Department of Obstetrics and Gynecology, Shinshu University School of Medicine, Matsumoto, Japan.; Nikaido T

Subjects: Leiomyosarcoma/Leiomyosarcoma/Leiomyosarcoma/*genetics ; Proto-Oncogene Proteins c-bcl-2/Proto-Oncogene Proteins c-bcl-2/Proto-Oncogene Proteins c-bcl-2/*genetics ; Uterine Neoplasms/Uterine Neoplasms/Uterine Neoplasms/*genetics

  • Source: British journal of cancer [Br J Cancer] 1999 Jul; Vol. 80 (10), pp. 1658-64.Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print Cited Medium:

Record details

×
  • 1-10 of  367 results for ""LEIOMYOSARCOMA""